First Time Loading...

Opthea Ltd
ASX:OPT

Watchlist Manager
Opthea Ltd Logo
Opthea Ltd
ASX:OPT
Watchlist
Price: 0.62 AUD Market Closed
Updated: May 2, 2024

Opthea Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Opthea Ltd
Revenue Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Opthea Ltd
ASX:OPT
Revenue
$117.1k
CAGR 3-Years
-23%
CAGR 5-Years
-35%
CAGR 10-Years
-19%
Immutep Ltd
ASX:IMM
Revenue
AU$256.6k
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-24%
Mesoblast Ltd
ASX:MSB
Revenue
$7.5m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Revenue
$14.2B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$87.3m
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
42%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A

See Also

What is Opthea Ltd's Revenue?
Revenue
117.1k USD

Based on the financial report for Dec 31, 2023, Opthea Ltd's Revenue amounts to 117.1k USD.

What is Opthea Ltd's Revenue growth rate?
Revenue CAGR 10Y
-19%

Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Opthea Ltd have been -23% over the past three years , -35% over the past five years , and -19% over the past ten years .